行气散瘀方联合三阶梯止痛疗法治疗恶性肿瘤癌痛临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R737.3

基金项目:

绍兴市柯桥区科技攻关计划项目(2018KZ53)


Clinical Study on Xingqi Sanyu Prescription Combined with Three- Step Hierarchy Cancer Pain Management for Cancer Pain of Malignant Tumor
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察行气散瘀方联合三阶梯止痛疗法治疗恶性肿瘤癌痛的临床疗效。方法:选取60 例恶性肿瘤癌痛患者,按随机数字表法分为对照组与治疗组各30 例。对照组采用世界卫生组织(WHO) 三阶梯止痛疗法进行镇痛,治疗组在对照组基础上联合行气散瘀方进行镇痛。14 d 为1 个观察周期,2 组共观察2 个周期。观察2 组临床疗效,比较2 组治疗前后疼痛数字评分法(NRS) 得分、生活质量(QOL) 的变化,比较2 组镇痛效果、镇痛药物用量,观察2 组治疗期间不良反应发生情况。结果:治疗2 个周期后,治疗组临床疗效总有效率为93.33%,高于对照组86.67%,2 组比较,差异无统计学意义(P>0.05)。治疗2 个周期后,2 组NRS 评分均较治疗前下降,治疗组NRS 评分低于对照组,差异均有统计学意义(P<0.05)。治疗2 个周期后,治疗组镇痛起效时间均短于对照组,镇痛持续时间长于对照组,差异有统计学意义(P<0.05)。治疗期间,治疗组镇痛药物盐酸羟考酮缓释片、盐酸吗啡片的药物用量及爆发痛次数均低于对照组,差异均有统计学意义(P<0.05)。治疗期间,治疗组恶心呕吐、便秘、乏力、头晕、嗜睡等不良反应发生率为13.33%,对照组不良反应发生率为40.00%,2 组比较,差异有统计学意义(P<0.05)。治疗2 个周期后,2 组社会功能、躯体功能、角色功能和认知功能4 个维度的生活质量评分均较治疗前升高(P<0.05);治疗后,治疗组生活质量的上述4 个维度评分均高于对照组,差异均有统计学意义(P<0.05)。结论:行气散瘀方联合三阶梯止痛疗法治疗恶性肿瘤癌痛的镇痛效果较好,可减少镇痛药物的剂量,改善生活质量,治疗方案安全性较高。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Xingqi Sanyu prescription combined with three- step hierarchy cancer pain management for cancer pain of malignant tumor. Methods: A total of 60 cases of patients with cancer pain of malignant tumor were selected and divided into the control group and the treatment group according to the random number table method, with 30 cases in each group. The control group was treated with three- step hierarchy cancer pain management of World Health Organization(WHO) for analgesia,and the treatment group was additionally treated with Xingqi Sanyu prescription based on the treatment of the control group. Both groups were observed for two cycles, with 14 days being a cycle. The clinical effects in the two groups were observed. The changes in Numerical Pain Rating Scale(NRS) scores and quality of life(QOL) before and after treatment as well as analgesic effect and analgesic drug dosage in the two groups were compared. During treatment,the incidences of adverse reactions in the two groups were observed. Results:After two cycles of treatment,the total effective rate of clinical effect was 93.33% in the treatment group,higher than that of 86.67% in the control group,there being no significant difference(P>0.05). After two cycles of treatment,NRS scores in the two groups were decreased when compared with those before treatment,and NRS score in the treatment group was lower than that in the control group,differences being significant(P<0.05). After two cycles of treatment,the onset time of analgesia in the treatment group was later than that in the control group,and the duration of analgesia was longer,the difference being significant(P<0.05). During the treatment, the dosage of analgesic drugs including oxycodone hydrochloride sustained- release tablets and morphine hydrochloride tablets as well as the frequency of pain outbreak in the treatment group were lower than those in the control group, differences being significant(P<0.05). During treatment, the incidence of adverse reactions such as nausea and vomiting, constipation, lack of strength, dizziness and somnolence was 13.33% in the treatment group and 40.00% in the control group,the difference being significant(P<0.05). After two cycles of treatment, QOL scores of social function,physical function,role function and cognitive function in the two groups were increased when compared with those before treatment(P<0.05);the QOL scores of the above four dimensions in the treatment group were higher than those in the control group, differences being significant(P<0.05). Conclusion: The therapy of Xingqi Sanyu prescription combined with three- step hierarchy cancer pain management for cancer pain of malignant tumor has a good analgesic effect,and can reduce the dosage of analgesic drugs and improve the quality of life,with high safety.

    参考文献
    相似文献
    引证文献
引用本文

朱伟伟,左芬,童康尔.行气散瘀方联合三阶梯止痛疗法治疗恶性肿瘤癌痛临床研究[J].新中医,2022,54(5):172-176

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-03-10
  • 出版日期:
文章二维码